Genetic Technologies Ltd (GENE)
Market Closed
14 Nov, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 77
0
0%
$
111.24M Market Cap
- P/E Ratio
- Div Yield
0 Volume
0 Eps
$ 0.77
Previous Close Want to track GENE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Genetic Technologies Ltd (GENE) Statistics
Valuation metrics
Market Cap 111.24M
Enterprise value 157.19M
Trailing P/E (ttm) -0.4
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 20.53
Price/Book (mrq) 2.73
Enterprise Value/Revenue 20.51
Enterprise Value/EBITDA -13.75
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 579
Average volume (90 days) 400
Price summary
52-Week low 0.67
52-Week high 3.59
Beta -
50-Day moving average 1,976.46
200-Day moving average 1,911.37
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 14 Dec 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.57%
Operating margin -1.59%
Operational effectiveness
Return on assets -1.94%
Return on equity -1.85%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.66
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.61
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.22
Total debt (mrq) -
Total Debt/Equity (mrq) 0.48
Current ratio (mrq) 0.88%
Book value per share (mrq) 0.4
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
